
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PSD-95 CRISPR/Cas9 KO Plasmid (m) | sc-420008 | 20 µg | $397.00 |
Dlg4 encodes postsynaptic density protein 95 (PSD-95), a major MAGUK scaffold that organizes excitatory synapses by clustering NMDA- and AMPA-type glutamate receptors with signaling enzymes and cytoskeletal regulators at the postsynaptic density. PSD-95 coordinates synaptic maturation and plasticity through pathways governing receptor trafficking, calcium-dependent signaling, and activity-dependent remodeling of dendritic spines. In mouse neuroscience models, altered Dlg4/PSD-95 function is widely used to interrogate mechanisms underlying excitatory/inhibitory balance and circuit connectivity, with relevance to neurodevelopmental and neuropsychiatric phenotypes. Its central role in synaptic signaling makes it a common target for dissecting glutamatergic transmission and plasticity in vitro and in vivo.
PSD-95 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Dlg4 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Dlg4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Dlg4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PSD-95 protein expression.
This CRISPR knockout system enables efficient generation of Dlg4-deficient cell models for investigation of PSD-95 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.